OPPOSITIONAL DEFIANT DISORDER (ODD): NEUROBIOLOGICAL ASPECTS, DIAGNOSIS, AND CLINICAL PERSPECTIVES

Authors

  • Rodrigo Fernando Campos Autor
  • Renato Discacciati Autor
  • Henri Ryoji Sasaki Filho Autor
  • Eliane Rossi Rocha Medeiros Autor
  • Rafael Kubo Ugatti de Souza Autor
  • Eddie Lloyd Galviz Fuentes Autor

DOI:

https://doi.org/10.63330/aurumpub.036-018

Keywords:

Neurobiology, Oppositional Defiant Disorder, Prefrontal cortex dysfunction, Emotion regulation, Psychiatric comorbidities

Abstract

Oppositional Defiant Disorder (ODD) is a neurodevelopmental condition characterized by a persistent pattern of irritable mood, defiant behavior, and vindictive attitudes. Although often dismissed as a “behavioral problem,” ODD involves measurable neurobiological alterations, a high familial burden, and significant functional impact. This article critically reviews the neurobiological foundations, diagnostic criteria, differential diagnoses, comorbidities, therapeutic approaches, and current limitations of clinical practice.

Downloads

Download data is not yet available.

References

1. Anderson JC, Williams S, McGee R, Silva PA. DSM-III disorders in Preadolescent children. Prevalence in a large sample from the general population. Arch Gen Psychiatry 1987;44(1):69-76.

2. Souza I, Serra MA, Mattos P, Franco VA. Comorbidade em crianças e adolescentes com transtorno do déficit de atenção: resultados preliminares. Arq Neuropsiquiatr. 2001; 59(2B):401-6.

3. Van Goozen SH, van den Ban E, Matthys W, Cohen-Kettenis PT,Thijssen JH, van Engeland H. Increased adrenal androgen functioning in children with oppositional defiant disorder: a comparison with psychiatric and normal controls. J Am Acad Child Adolesc Psychiatry.2000;39(11):1446-51.

4. Van Goozen SH, Matthys W, Cohen-Kettenis PT, Buitelaar JK, van engeland H. Hypothalamic-pituitary-adrenal axis and autonomic nervous system activity in disruptive children and matched controls. J Am Acad Child Adolesc Psychiatry. 2000; 39(11):1438-45.

5. Van Goozen SH, Matthys W, Cohen-Kettenis PT, Westenberg H, van engeland H. Plasma monoamine metabolites and aggression:two studies Of normal and oppositional defiant disorder children. Eur Neuropsychopharmacol. 1999; 9(1- 2):141-7.

6. Snoek H, van Goozen SH, Matthys W, Sigling HO, Koppeschaar HP, Westenberg HG, van Engeland H. Serotonergic functioning in children with oppositional defiant disorder: a sumatriptan challenge study. Biol psychiatry. 2002;51(4):319-25.

7. Clarke AR, Barry RJ, McCarthy R, Selikowitz M. Children with attention- deficit/hyperactivity disorder and comorbid oppositional defiant disorder:na EEG analysis. Psychiatry Res. 2002;111(2-3):181-90.

8. Kim MS, Kim JJ, Kwon JS. Frontal P300 decrement and executive dysfunction in adolescents with conduct problems. Child Psychiatry Hum dev. 2001;32(2):93-106.

9. Nadder TS, Rutter M, Silberg JL, Maes HH, Eaves LJ. Genetic effects ont he variation and covariation of attention-deficit-hyperactivity disorder (ADHD) and oppositional-defiant disorder/conduct disorder (Odd/CD) symptomatologies across informant and occasion of measurement. Psychol Med. 2002;32(1):39-53.

10. Comings DE, Wu S, Chiu C, Ring RH, Gade R, Ahn C, et al. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes—DRD2, D beta H, and DAT1. Am J Med Genet. 1996;67(3):264-88

Published

2026-02-26

How to Cite

OPPOSITIONAL DEFIANT DISORDER (ODD): NEUROBIOLOGICAL ASPECTS, DIAGNOSIS, AND CLINICAL PERSPECTIVES. (2026). Aurum Editora, 151-158. https://doi.org/10.63330/aurumpub.036-018

Publications by the same author